ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1315

Exploring the Prevalence and Factors Associated with Fatigue in Axial Spondyloarthritis in a Multiethnic Asian Cohort in Singapore

Wei Ze Lim1, Warren Fong2, Yu Heng Kwan3 and Ying Ying Leung2, 1Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore, Singapore, 2Department of Rheumatology and Immunology, Singapore General Hospital, Singapore, Singapore, Singapore, 3Duke-NUS Medical School, Singapore, Singapore, Singapore

Meeting: ACR Convergence 2020

Keywords: Ankylosing spondylitis (AS), Fatigue, spondyloarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2020

Title: Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster II: Extra-MSK & Comorbidities

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Fatigue is a cardinal symptom of axial spondyloarthritis (axSpA) that poses management challenges. Data on fatigue amongst Asian patients with axSpA is limited. Ethnicity and geographic differences may shape the disease manifestations, severity and comorbidities. In this study, we aim to evaluate the prevalence of fatigue and the factors associated with fatigue among patients with axSpA within a multi-ethnic Asian population.

Methods: We used the baseline data from a clinic registry in Singapore General Hospital. All patients fulfilled the 2009 Assessment of SpondyloArthritis international Society (ASAS) classification criteria for axSpA. Fatigue was assessed using the Bath Ankylosing Spondylitis Disease Activity Index fatigue item (BASDAI-fatigue) and the Short Form-36 Health Survey vitality domain (SF-36 VT). Severe fatigue was defined as BASDAI-fatigue ≥ 5/10 and SF-36 VT ≤ 10th percentile of the general Singaporean population.

Results: We included 262 consecutive patients with axSpA (79% men, 82.4% Chinese). The mean (standard deviation, SD) age and duration of disease were 41.7 (13.7) and 10.1 (8.3) years respectively. 145 (55.3%) patients reported severe fatigue by the BASDAI-fatigue criteria; 52 (31.1%) patients out of 167 with available SF-36 data had severe fatigue by the VT criteria. Patients with severe fatigue had worse scores across all disease activity assessments: BASDAI-axial pain, peripheral joint pain, morning stiffness and Spondyloarthritis Research Consortium of Canada (SPARCC) enthesitis index; and disease impact measures: Bath Ankylosing Spondylitis Patient Global Score (BAS-G), Bath Ankylosing Spondylitis Functional Index (BASFI), Ankylosing Spondylitis Quality of Life (ASQoL) and all SF-36 domains, compared to those without severe fatigue (Table 1). In the principal component analyses (Figure 1), disease activity and disease impact were statistically significantly associated with BASDAI-fatigue, while disease activity, disease impact and disease chronicity were associated with SF-36 VT. In the univariable analyses, all disease activity assessments and disease impact measures correlated with both BASDAI-fatigue and SF-36 VT; education level correlated with BASDAI-fatigue, while damaged joint count and age correlated with SF-36 VT. In the multivariable analyses, BASDAI-axial pain, BASFI, BAS-G and ethnicity were associated with BASDAI-fatigue, while ASQoL and BASDAI-morning stiffness were associated with SF-36 VT (Table 2).

Conclusion: Fatigue is prevalent amongst patients with axSpA in Asia and is associated with disease activity, disease impact as well as patient related factors including education level and ethnicity.

Table 1. Baseline characteristics of patients with axSpA

Table 2. Factors associated with BASDAI-F and SF-36 VT on multiple linear regression

Figure 1. Principal component analysis yielding 6 components with eigenvalue greater than 1


Disclosure: W. Lim, None; W. Fong, None; Y. Kwan, None; Y. Leung, Novartis, 1, Jassen, 1, AbbVie, 1, Eli Lilly, 1.

To cite this abstract in AMA style:

Lim W, Fong W, Kwan Y, Leung Y. Exploring the Prevalence and Factors Associated with Fatigue in Axial Spondyloarthritis in a Multiethnic Asian Cohort in Singapore [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/exploring-the-prevalence-and-factors-associated-with-fatigue-in-axial-spondyloarthritis-in-a-multiethnic-asian-cohort-in-singapore/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/exploring-the-prevalence-and-factors-associated-with-fatigue-in-axial-spondyloarthritis-in-a-multiethnic-asian-cohort-in-singapore/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology